8-03-2023, 18:34

Kineta to Present at the Oppenheimer 33rd Annual Healthcare

SEATTLE, March 08, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused
Globe Newswire8-03-2023, 18:34
6-03-2023, 18:39

Kineta to Host Key Opinion Leader Event on KVA12123: VISTA

SEATTLE, March 06, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused
Globe Newswire6-03-2023, 18:39
1-03-2023, 18:52

Kineta Appoints Internationally-Renowned Clinical

SEATTLE, March 01, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused
Globe Newswire1-03-2023, 18:52